Leukocyte-derived chemotoxin 2 (LECT2), a tumor suppressor in HCC, contributes to blocking vascular invasion and metastasis in HCC by recruiting PTPN1 to antagonize MET receptor activation (143). The gene discussed is PTPN1; the disease is hepatocellular carcinoma.